0001019056-17-000547.txt : 20170601 0001019056-17-000547.hdr.sgml : 20170601 20170601213949 ACCESSION NUMBER: 0001019056-17-000547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170601 DATE AS OF CHANGE: 20170601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamothe Jeffrey G. CENTRAL INDEX KEY: 0001679967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 17886315 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 lamothe_4.xml OWNERSHIP DOCUMENT X0306 4 2017-06-01 0 0001671584 Aptevo Therapeutics Inc. APVO 0001679967 Lamothe Jeffrey G. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 0 1 0 0 SVP, CFO and Treasurer Employee Stock Option (right to buy) 2.15 2017-06-01 4 A 0 33700 0 A 2027-05-31 Common Stock 33700 33700 D The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017. The option vests in three equal annual installments beginning on June 1, 2018. /s/ Benjamin J. Stein, attorney-in-fact 2017-06-01